Icon

EDARBYCLOR (nda202331)- (EQ 40MG MEDOXOMIL;12.5MG,EQ 40MG MEDOXOMIL;25MG)

AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE AZURITY
EQ 40MG MEDOXOMIL;12.5MG,EQ 40MG MEDOXOMIL;25MG
Yes Yes
2031-Jul-01 2016-Feb-25
None None
None No
Edarbyclor is a combination of azilsartan medoxomil, an angiotensin II receptor blocker (ARB) and chlorthalidone, a thiazide-like diuretic combination product indicated for the treatment of hypertension, to lower blood pressure: • In patients not adequately controlled with monotherapy • As initial therapy in patients likely to need multiple drugs to help achieve blood pressure goals.
0 3 0
Total Other Developers 23
Drugs with Suitability No
EQ 40MG MEDOXOMIL;12.5MG ** ** Up - -
EQ 40MG MEDOXOMIL;25MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.